Operating Lease, Liability of Dianthus Therapeutics, Inc. /DE/ from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Liability for the quarter ending 30 Sep 2025 was $1,285,000, a 313% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,285,000 +$974,000 +313% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,330,000 +$923,000 +227% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,396,000 +$899,000 +181% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,491,000 +$906,000 +155% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $311,000 -$359,000 -54% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $407,000 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $497,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $585,000 -$203,000 -26% 31 Dec 2023 10-K 21 Mar 2024 2023 FY
Q3 2023 $670,000 -$30,128,000 -98% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q4 2022 $788,000 31 Dec 2022 8-K 21 Dec 2023
Q3 2022 $30,798,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $31,610,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $32,350,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.